Gail Boudreaux - 18 Jul 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
18 Jul 2025
Net transactions value
+$2,438,951
Form type
4
Filing time
18 Jul 2025, 13:42:51 UTC
Previous filing
14 Mar 2025
Next filing
04 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BOUDREAUX GAIL President and CEO, Director 220 VIRGINIA AVENUE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 18 Jul 2025 0001287920

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Purchase $667,687 +2,334 +1.6% $286.07 144,854 18 Jul 2025 Direct F1
transaction ELV Common Stock Purchase $1,468,906 +5,116 +3.5% $287.12 149,970 18 Jul 2025 Direct F2
transaction ELV Common Stock Purchase $302,358 +1,050 +0.7% $287.96 151,020 18 Jul 2025 Direct F3
holding ELV Common Stock 60 18 Jul 2025 Shares Held in Spouse's Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.